Article
The Immune System – Friend or Foe for Adenovirus Based Therapies?
2024-05-27
Abstract excerpt
Pathogenic adenovirus (Ad) infections are widespread but typically mild and transient, except in the immunocompromised. As vectors for gene therapy, vaccine and oncology applications, Ad based platforms offer advantages including ease of genetic manipulation, scale of production and well established safety profiles, making them attractive tools for therapeutic development. However, the immune system often poses a...
Topics
Open a Topic to create a Post that cites this publication.
- CAR-T cell therapy research
- CRISPR and Genetic Engineering
- Cytomegalovirus and herpesvirus research
- RNA Interference and Gene Delivery
- Viral gastroenteritis research and epidemiology
- Viral Infections and Immunology Research
- Viral Infectious Diseases and Gene Expression in Insects
- Virus-based gene therapy research
Identifiers and source
- Literature Corpus work
- f07e3c9d-cfda-530b-9dc3-d88706a39d80
- DOI
- 10.20944/preprints202405.1698.v1
